Literature DB >> 35730658

Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.

Riccardo Cau1, Cinzia Solinas2, Pushpamali De Silva3, Matteo Lambertini4,5, Elisa Agostinetto6,7, Mario Scartozzi8, Roberta Montisci9, Gianluca Pontone10, Michele Porcu1, Luca Saba1.   

Abstract

Immune checkpoint inhibitor (ICI)-induced cardiotoxicity is a rare immune-related adverse event (irAE) characterized by a high mortality rate. From a pathological point of view, this condition can result from a series of causes, including binding of ICIs to target molecules on nonlymphocytic cells, cross-reaction of T lymphocytes against tumor antigens with off-target tissues, generation of autoantibodies and production of proinflammatory cytokines. The diagnosis of ICI-induced cardiotoxicity can be challenging, and cardiac magnetic resonance (CMR) represents the diagnostic tool of choice in clinically stable patients with suspected myocarditis. CMR is gaining a central role in diagnosis and monitoring of cardiovascular damage in cancer patients, and it is entering international cardiology and oncology guidelines. In this narrative review, we summarized the clinical aspects of ICI-associated myocarditis, highlighting its radiological aspects and proposing a novel algorithm for the use of CMR.
© 2022 UICC.

Entities:  

Keywords:  CMR; ICI; cardiotoxicity; myocarditis

Mesh:

Substances:

Year:  2022        PMID: 35730658     DOI: 10.1002/ijc.34169

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.316


  1 in total

Review 1.  Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.

Authors:  Mireille Langouo Fontsa; Marco Maria Aiello; Edoardo Migliori; Mario Scartozzi; Matteo Lambertini; Karen Willard-Gallo; Cinzia Solinas
Journal:  Target Oncol       Date:  2022-09-14       Impact factor: 4.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.